ProSciento partners with OWL Metabolomics to advance recruitment strategies for NASH clinical studies

ProSciento partners with OWL Metabolomics to advance recruitment strategies for NASH clinical studies

Chula Vista’s ProSciento allies with Spanish biotech on liver diseases

Bradley J. FikesBradley J. Fikes

Seeking to advance clinical trials on liver diseases, ProSciento, a clinical services provider based in Chula Vista, has signed a multi-year partnership with the Spanish biotechnology company Owl Metabolomics.

Read the full article at the Union Tribune »